TrialCancer research and treatment2024

Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non-Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial.

Junghoon Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.